在阵发性夜间血红蛋白尿患者中使用依库珠单抗后成功停用抗凝治疗。 - Suppr

Suppr

超能文献

Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria.

作者信息

Emadi Ashkan, Brodsky Robert A

出版信息

Am J Hematol. 2009 Oct;84(10):699-701. doi: 10.1002/ajh.21506.

DOI:10.1002/ajh.21506

PMID:19705437

Abstract

摘要

相似文献

Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria.在阵发性夜间血红蛋白尿患者中使用依库珠单抗后成功停用抗凝治疗。

Am J Hematol. 2009 Oct;84(10):699-701. doi: 10.1002/ajh.21506.

Eculizumab in paroxysmal nocturnal hemoglobinuria.依库珠单抗治疗阵发性睡眠性血红蛋白尿症。

N Engl J Med. 2006 Dec 28;355(26):2786; author reply 2787-8. doi: 10.1056/NEJMc062885.

[Successful eculizumab treatment for multiple coronary thrombosis complicated in paroxysmal nocturnal hemoglobinuria].[依库珠单抗成功治疗阵发性夜间血红蛋白尿并发的多发性冠状动脉血栓形成]

Rinsho Ketsueki. 2014 Aug;55(8):965-9.

Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux.阵发性夜间血红蛋白尿症继发于用阿仑单抗进行免疫抑制治疗骨髓增生异常综合征，并伴有复发性危及生命的血栓形成，尽管进行了抗凝治疗：用依库珠单抗和磺达肝癸钠成功干预。

Leuk Res. 2010 Apr;34(4):e85-7. doi: 10.1016/j.leukres.2009.09.024.

Eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.依库珠单抗用于治疗阵发性夜间血红蛋白尿症。

Clin Adv Hematol Oncol. 2005 Nov;3(11):849-50.

Neutrophil activation and nucleosomes as markers of systemic inflammation in paroxysmal nocturnal hemoglobinuria: effects of eculizumab.中性粒细胞活化和核小体作为阵发性睡眠性血红蛋白尿症系统性炎症的标志物：依库珠单抗的作用。

J Thromb Haemost. 2015 Nov;13(11):2004-11. doi: 10.1111/jth.13125. Epub 2015 Oct 19.

Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab.阵发性夜间血红蛋白尿患者停用依库珠单抗后可能存在血栓形成事件的高风险。

Br J Haematol. 2012 Jun;157(6):762-3. doi: 10.1111/j.1365-2141.2012.09073.x. Epub 2012 Feb 29.

Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab.阵发性夜间血红蛋白尿患者接受抗补体抗体依库珠单抗治疗后成功进行布加综合征肝移植。

Liver Transpl. 2009 May;15(5):540-3. doi: 10.1002/lt.21714.

Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab.依库珠单抗时代的阵发性夜间血红蛋白尿（PNH）与妊娠

Leuk Res. 2009 Jun;33(6):e4-5. doi: 10.1016/j.leukres.2008.09.008. Epub 2008 Oct 25.

Eculizumab for patients with paroxysmal nocturnal hemoglobinuria (PNH) is effective during the maintenance of hemodialysis for end stage renal failure.依库珠单抗用于阵发性夜间血红蛋白尿（PNH）患者，在终末期肾衰竭血液透析维持治疗期间是有效的。

Leuk Res. 2011 Apr;35(4):560-2. doi: 10.1016/j.leukres.2010.10.021. Epub 2010 Dec 8.

引用本文的文献

Paroxysmal Nocturnal Hemoglobinuria: A Case Report in a Pandemic Environment.阵发性夜间血红蛋白尿：大流行环境下的一例病例报告

Reports (MDPI). 2023 Sep 8;6(3):42. doi: 10.3390/reports6030042.

Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment.阵发性睡眠性血红蛋白尿症（PNH）中的血栓形成：从发病机制到治疗。

Int J Mol Sci. 2024 Nov 11;25(22):12104. doi: 10.3390/ijms252212104.

Etiologies of Splenic Venous Hypertension: A Review.脾静脉高压的病因：综述

J Clin Transl Hepatol. 2024 Jun 28;12(6):594-606. doi: 10.14218/JCTH.2024.00054. Epub 2024 May 20.

Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysis.新型治疗时代阵发性睡眠性血红蛋白尿症相关血栓形成：一项 2043 患者年的分析。

Blood. 2024 Jul 11;144(2):145-155. doi: 10.1182/blood.2024023988.

Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival.免疫抑制治疗再生障碍性贫血后出现复发和向骨髓增生异常综合征和急性髓系白血病转化的情况比异基因造血干细胞移植更为常见，对生存有负面影响。

Ann Hematol. 2024 Mar;103(3):749-758. doi: 10.1007/s00277-024-05621-2. Epub 2024 Jan 20.

Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones.瑞士关于引发对阵发性睡眠性血红蛋白尿克隆检测的临床症候群的当前实践与观点调查。

Front Med (Lausanne). 2023 Jul 26;10:1200431. doi: 10.3389/fmed.2023.1200431. eCollection 2023.

Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study.阵发性睡眠性血红蛋白尿（PNH）患者的血栓栓塞事件：一项希腊全国多中心回顾性研究的真实世界数据

Front Oncol. 2023 Mar 7;13:1128994. doi: 10.3389/fonc.2023.1128994. eCollection 2023.

Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia.循环内皮祖细胞及其与阵发性睡眠性血红蛋白尿症和再生障碍性贫血中血栓形成的关系。

Indian J Hematol Blood Transfus. 2022 Apr;38(2):319-326. doi: 10.1007/s12288-021-01445-6. Epub 2021 May 26.

Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature.骨髓增殖性肿瘤背景下的阵发性夜间血红蛋白尿：一例报告及文献复习

Front Oncol. 2021 Nov 11;11:756589. doi: 10.3389/fonc.2021.756589. eCollection 2021.

A 15-year, single institution experience of anticoagulation management in paroxysmal nocturnal hemoglobinuria patients on terminal complement inhibition with history of thromboembolism.一项为期15年的单机构经验，涉及阵发性夜间血红蛋白尿患者在接受终末补体抑制治疗且有血栓栓塞病史时的抗凝管理。

Am J Hematol. 2022 Feb 1;97(2):E59-E62. doi: 10.1002/ajh.26414. Epub 2021 Nov 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验